New insight on the systemic inflammation response syndrome (SIRS) in STEMI patients undergoing primary percutaneous intervention: clinical features, blood markers, and prognostic significance (2013)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: ANGIOPLASTIA; INFLAMAÇÃO; INFARTO DO MIOCÁRDIO (CARACTERÍSTICAS;PROGNÓSTICO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Thrombosis and Haemostasis
- ISSN: 1538-7933
- Volume/Número/Paginação/Ano: v.11, suppl. 2, p. 859, res. PB3.66-1, 2013
- Conference titles: Congress of the International Society on Thrombosis and Haemostasis
-
ABNT
THÉROUX, P. et al. New insight on the systemic inflammation response syndrome (SIRS) in STEMI patients undergoing primary percutaneous intervention: clinical features, blood markers, and prognostic significance. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf. Acesso em: 04 out. 2024. , 2013 -
APA
Théroux, P., Luong, T. M., Nicolau, J. C., & Bonnefoy, A. (2013). New insight on the systemic inflammation response syndrome (SIRS) in STEMI patients undergoing primary percutaneous intervention: clinical features, blood markers, and prognostic significance. Journal of Thrombosis and Haemostasis. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf -
NLM
Théroux P, Luong TM, Nicolau JC, Bonnefoy A. New insight on the systemic inflammation response syndrome (SIRS) in STEMI patients undergoing primary percutaneous intervention: clinical features, blood markers, and prognostic significance [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 859.[citado 2024 out. 04 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf -
Vancouver
Théroux P, Luong TM, Nicolau JC, Bonnefoy A. New insight on the systemic inflammation response syndrome (SIRS) in STEMI patients undergoing primary percutaneous intervention: clinical features, blood markers, and prognostic significance [Internet]. Journal of Thrombosis and Haemostasis. 2013 ;11 859.[citado 2024 out. 04 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/jth.12284/pdf - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
